Skip to main content
PCL. Inc logo

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2022-02-21 Regulatory Filings
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean DART system regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) and a subsequent amendment (정정신고). It details a contract with Omnimedical Ltd, including contract amounts, dates, and terms. Since this is a specific regulatory disclosure of a commercial contract and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-02-21 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean DART system regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It is a correction filing (정정신고) for a previously disclosed contract, providing specific details about the counterparty and supply region that were previously withheld for confidentiality. Since this is a specific regulatory disclosure of a commercial contract and does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2022-02-18 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sales/Supply Contract' amendment. It details the correction of a previous disclosure (dated 2021-02-18) to reveal the counterparty and supply region after a confidentiality period expired. Since this is a specific regulatory disclosure regarding a commercial contract and does not fit into categories like M&A, dividends, or financial reports, it is classified as a general Regulatory Filing (RNS).
2022-02-16 Korean
파생상품거래손실발생
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Loss from Derivatives Transaction' (파생상품거래손실발생). It details accounting losses related to convertible bonds (CB) valuation under K-IFRS. Since this is a specific regulatory disclosure regarding financial events that does not fit into standard categories like earnings releases or annual reports, it falls under the general regulatory filing category.
2022-02-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) announcing a significant change (over 15-30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for material financial changes. Since it provides specific financial highlights and reasons for the change rather than just announcing the availability of a report, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial performance results. FY 2021
2022-02-14 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean company PCL regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It is a correction report (정정신고) updating details of a previously disclosed contract, specifically revealing the counterparty name and supply region after a confidentiality period expired. Since this is a specific regulatory disclosure regarding a commercial contract and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-02-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.